Founders Capital Management (Texas)’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Founders Capital Management (Texas)’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-731	Closed	-$46K	–	338
2018 Q1	$46K	Buy	731 +1	+0.1%	+$66	0.04%	142
2017 Q4	$47K	Buy	730 +1	+0.1%	+$64	0.04%	142
2017 Q3	$48K	Buy	729 +2	+0.3%	+$126	0.04%	143
2017 Q2	$46K	Hold	727	–	–	0.04%	143
2017 Q1	$43K	Buy	+727	New	+$42.5K	0.04%	147

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Founders Capital Management (Texas)'s PJP Position: Q2 2018 in Review

Founders Capital Management (Texas) sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 731 shares — an estimated $46K sold.

Founders Capital Management (Texas) first reported a position in PJP in Q1 2017 and held it in 5 quarters. The position peaked at $48K in Q3 2017. 85 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

Founders Capital Management (Texas) reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Founders Capital Management (Texas) sold 731 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $46K.
Founders Capital Management (Texas) first reported a position in Invesco Pharmaceuticals ETF in Q1 2017 and held it in 5 quarters.
Founders Capital Management (Texas)'s Invesco Pharmaceuticals ETF position peaked at $48K in Q3 2017.
85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2018, filed 9 Jul 2018.